HOOKIPA Pharma Inc. Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
HOOKIPA Pharma Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • HOOKIPA Pharma Inc. Costs and Expenses for the quarter ending September 30, 2024 was $23.3M, a 21% decline year-over-year.
  • HOOKIPA Pharma Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $111M, a 9.86% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Costs and Expenses for 2023 was $118M, a 34.8% increase from 2022.
  • HOOKIPA Pharma Inc. annual Costs and Expenses for 2022 was $87.4M, a 12.7% decline from 2021.
  • HOOKIPA Pharma Inc. annual Costs and Expenses for 2021 was $100M, a 37.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $118M +$30.4M +34.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $87.4M -$12.7M -12.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $100M +$27.3M +37.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 $72.9M +$9.84M +15.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $63M +$34.2M +119% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-24
2018 $28.8M +$14.7M +103% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $14.2M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.